10 results
10-K
2020 FY
LABP
Landos Biopharma Inc
31 Mar 21
Annual report
5:03pm
;
the possible misappropriation of our proprietary information, including our trade secrets and know-how;
the possible increase in costs for the raw … materials for our product candidates; and
the possible termination or nonrenewal of any agreement by any third party at a time that is costly
424B4
LABP
Landos Biopharma Inc
4 Feb 21
Prospectus supplement with pricing info
5:02pm
for the raw materials for our product candidates; and
the possible termination or nonrenewal of any agreement by any third party at a time that is costly
S-1/A
o8efaym52945f2np q0
28 Jan 21
IPO registration (amended)
9:12am
S-1
u54mgcdd6e9 a6o9rjm
13 Jan 21
IPO registration
5:07pm
DRS/A
yzu0c0oy565y
1 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
1032n7s 45nyd0i64
1 Sep 20
Draft registration statement (amended)
12:00am
DRS
3n4knij s1
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next